Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock, par value $.0001 per share
-
Shares outstanding
-
6.87M
-
Number of holders
-
57
-
Total 13F shares, excl. options
-
31.1M
-
Shares change
-
-403K
-
Total reported value, excl. options
-
$362M
-
Value change
-
-$5.7M
-
Number of buys
-
28
-
Number of sells
-
-15
-
Price
-
$11.62
Significant Holders of Vor Biopharma Inc. - Common Stock, par value $.0001 per share (VOR) as of Q4 2021
61 filings reported holding VOR - Vor Biopharma Inc. - Common Stock, par value $.0001 per share as of Q4 2021.
Vor Biopharma Inc. - Common Stock, par value $.0001 per share (VOR) has 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.1M shares
.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (11.1M shares), 5AM Venture Management, LLC (6.36M shares), FMR LLC (3.18M shares), BlackRock Inc. (1.4M shares), Woodline Partners LP (1.11M shares), JOHNSON & JOHNSON (1.07M shares), VANGUARD GROUP INC (952K shares), Laurion Capital Management LP (857K shares), ORBIMED ADVISORS LLC (833K shares), and Sarissa Capital Management LP (707K shares).
This table shows the top 57 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.